# Theratechnologies Inc. (THTX)

Source: https://www.quantisnow.com/company/THTX
Generated: 2026-11-11T14:44:34.196Z

- Ticker: THTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: theratech.com

## About

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

## Latest THTX news and filings

- 2025-11-14 21:36 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-theratechnologies-inc-6281024)
- 2025-09-25 20:08 UTC [SEC Form 25-NSE filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-theratechnologies-inc-6211913)
- 2025-09-25 18:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6211751)
- 2025-09-25 17:21 UTC [Theratechnologies Announces Completion of Acquisition by Future Pak](https://www.quantisnow.com/insight/theratechnologies-announces-completion-of-acquisition-by-future-pak-6211730)
- 2025-09-17 14:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6203644)
- 2025-09-16 21:10 UTC [Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak](https://www.quantisnow.com/insight/theratechnologies-receives-final-court-approval-of-proposed-plan-of-arrangement-6202812)
- 2025-09-12 20:22 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6199416)
- 2025-09-12 18:07 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6199140)
- 2025-09-12 15:23 UTC [Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak](https://www.quantisnow.com/insight/theratechnologies-shareholders-approve-proposed-plan-of-arrangement-to-be-acquired-6199029)
- 2025-09-05 19:32 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6191521)
- 2025-09-05 11:30 UTC [Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy](https://www.quantisnow.com/insight/theratechnologies-announces-availability-of-egrifta-wr-tesamorelin-for-injection-to-6191051)
- 2025-09-02 17:26 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6185522)
- 2025-09-02 11:30 UTC [Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote "FOR" the Proposed Plan of Arrangement with Future Pak](https://www.quantisnow.com/insight/theratechnologies-announces-independent-proxy-advisor-firms-iss-and-glass-lewis-6184748)
- 2025-08-18 12:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6169402)
- 2025-08-18 11:52 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6169321)
- 2025-08-18 11:30 UTC [Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak](https://www.quantisnow.com/insight/theratechnologies-announces-filing-of-special-meeting-materials-and-receipt-of-6169292)
- 2025-08-05 19:08 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-theratechnologies-inc-6147034)
- 2025-07-29 20:05 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-theratechnologies-inc-6136473)
- 2025-07-18 20:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6125377)
- 2025-07-10 15:07 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6116582)
- 2025-07-09 14:11 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6115224)
- 2025-07-09 14:04 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6115223)
- 2025-07-09 13:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6115161)
- 2025-07-09 12:35 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6115097)
- 2025-07-09 11:30 UTC [Earnings] [Theratechnologies Reports Financial Results for the Second Quarter 2025](https://www.quantisnow.com/insight/theratechnologies-reports-financial-results-for-the-second-quarter-2025-6114879)
- 2025-07-03 21:30 UTC [Earnings Date] [Theratechnologies to Announce Second Quarter 2025 Financial Results](https://www.quantisnow.com/insight/theratechnologies-to-announce-second-quarter-2025-financial-results-6111561)
- 2025-07-03 18:09 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6110611)
- 2025-07-03 02:11 UTC [Dividends] [Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak](https://www.quantisnow.com/insight/theratechnologies-enters-into-definitive-agreement-to-be-acquired-by-cb-6109925)
- 2025-05-29 18:31 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6062873)
- 2025-05-29 18:00 UTC [Theratechnologies Reports on its Annual Meeting of Shareholders](https://www.quantisnow.com/insight/theratechnologies-reports-on-its-annual-meeting-of-shareholders-6062853)
- 2025-05-02 20:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-6016002)
- 2025-05-02 11:30 UTC [Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV](https://www.quantisnow.com/insight/theratechnologies-presents-novel-data-at-acthiv-2025-underscoring-importance-of-6014769)
- 2025-04-16 14:51 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-5989803)
- 2025-04-15 22:00 UTC [Theratechnologies Provides Update on Sale Process](https://www.quantisnow.com/insight/theratechnologies-provides-update-on-sale-process-5989063)
- 2025-04-15 15:47 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-5988102)
- 2025-04-12 12:46 UTC [Soleus Capital Issues Letter to The Board of Theratechnologies](https://www.quantisnow.com/insight/soleus-capital-issues-letter-to-the-board-of-theratechnologies-5985998)
- 2025-04-11 21:00 UTC [Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company](https://www.quantisnow.com/insight/theratechnologies-responds-to-future-paks-press-release-and-announces-exclusive-5985711)
- 2025-04-11 13:57 UTC [Future Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total Value](https://www.quantisnow.com/insight/future-pak-submits-proposals-to-acquire-theratechnologies-inc-offering-up-5985295)
- 2025-04-09 13:51 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-5982510)
- 2025-04-09 13:22 UTC [SEC Form 6-K] [SEC Form 6-K filed by Theratechnologies Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-theratechnologies-inc-5982489)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/THTX
- Earnings history: https://www.quantisnow.com/earnings/THTX
- Dividend history: https://www.quantisnow.com/dividends/THTX
- Insider transactions: https://www.quantisnow.com/insiders/THTX
- Options chain: https://www.quantisnow.com/options/THTX
- SEC 8-K filings only: https://www.quantisnow.com/company/THTX/8-k
- RSS and alerts for THTX: https://www.quantisnow.com/docs/rss-feeds.md